abs263.txt	the	optimal	management	of	patients	with	locally	advanced	esophageal	cancerremains	under	debate		we	aimed	to	compare	the	long-term	survival	outcomes	betweendefinitive	chemoradiation	(dcr)	and	chemoradiation	plus	surgery	(crs)	in	patientswith	stage	iii	esophageal	adenocarcinoma	(eac)		using	the	national	cancerinstitute	surveillance		epidemiology		and	end	results	(seer)	program	registry	adults	(â‰¥	18	years	old)	with	diagnosis	of	ajcc	6th	edition	stage	iii	eac	(t3/n1	t4/n0		and	t4/n1)	between	2004	and	2014	were	included		a	multivariable	coxregression	was	used	to	assess	the	effect	of	dcr	and	crs	on	mortality		of	the	2633patients	included		1115	(42%)	underwent	dcr		and	1518	(58%)	underwent	crs		the5-year	survival	rate	was	13%	for	patients	undergoing	dcr	and	27%	for	patientsundergoing	crs	(p	<	0	0001)		our	observational	data	suggest	that	patients	withstage	iii	eac	may	benefit	by	the	use	of	esophagectomy	after	chemoradiotherapy	
